Weight-loss drugs to compete on biggest stage with Super Bowl ads [Yahoo! Finance Canada]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Yahoo! Finance Canada
FILE PHOTO: A combination image shows an injection pen of Zepbound, Eli Lilly's weight loss drug, and boxes of Wegovy, made by Novo Nordisk. REUTERS/Hollie Adams/Brendan McDermid/Combination/File Photo By Amina Niasse 3 min read In this article By Amina Niasse NEW YORK, Feb 7 (Reuters) - Companies looking to sell weight-loss drugs directly to consumers, including Novo Nordisk's Wegovy, will shell out millions of dollars for celebrity-filled ads during Sunday's Super Bowl with its promise of one of the year's ?largest global audiences. Novo's 90-second spot has comedian and SNL stalwart Kenan Thompson announcing the new Wegovy pill to America and suggesting, ?tongue-in-cheek along with music producer DJ Khaled, that people with obesity can benefit from the drug just like they would a pill for parallel parking or saving kittens in trees. Telehealth ?company Ro will bring out tennis star Serena Williams in its first Super Bowl ad, while a Hims & Hers Health commercial feat
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Novo is suing Hims & Hers to halt obesity drug copycats [Los Angeles Times (CA)]Los Angeles Times
- Eli Lilly and Company (NYSE:LLY) had its price target raised by analysts at Deutsche Bank Aktiengesellschaft from $1,200.00 to $1,285.00. They now have a "buy" rating on the stock.MarketBeat
- Lilly to acquire Orna Therapeutics to advance cell therapiesPR Newswire
- Eli Lilly and Company (NYSE:LLY) had its price target raised by analysts at Leerink Partners from $1,234.00 to $1,296.00. They now have an "outperform" rating on the stock.MarketBeat
- Goldman Sachs Reaffirms Buy on Eli Lilly and Company (LLY), Citing 25% Growth Outlook [Yahoo! Finance]Yahoo! Finance
LLY
Earnings
- 2/4/26 - Beat
LLY
Sec Filings
- 2/4/26 - Form 8-K
- 2/3/26 - Form 4
- 2/3/26 - Form 4
- LLY's page on the SEC website